AZN – astrazeneca plc - american depositary shares (US:NASDAQ)

News

AstraZeneca PLC (NASDAQ: AZN) had its price target raised by analysts at BMO Capital Markets from $80.00 to $82.00. They now have an "outperform" rating on the stock.
Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates [Yahoo! Finance]
AstraZeneca: Strong In A Weak Market [Seeking Alpha]
Regenerative Medicine Market Size Expected to Reach USD 154.05 Bn by 2033 [Yahoo! Finance]
Fusion (FUSN) to Report Q1 Earnings: Here's What to Expect [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com